Shopping Cart 0
Cart Subtotal
USD 0

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500

Details

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Treatment Resistant Depression Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Treatment Resistant Depression Therapeutics Clinical Trials 29

Prominent Drugs 30

Latest Clinical Trials News on Treatment Resistant Depression 31

Oct 15, 2019: Relmada Therapeutics announces top-line results from REL-1017 phase 2 study in individuals with treatment resistant depression 31

Oct 14, 2019: Relmada Therapeutics to announce results of phase 2 study of REL-1017 for treatment resistant depression and conduct Conference Call 31

Clinical Trial Profile Snapshots 32

Appendix 228

Abbreviations 228

Definitions 228

Research Methodology 229

Secondary Research 229

About GlobalData 230

Contact Us 230

Source 231


List Of Figure

List of Figures

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Treatment Resistant Depression Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Treatment Resistant Depression Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Treatment Resistant Depression Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Treatment Resistant Depression Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Treatment Resistant Depression Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14

Treatment Resistant Depression Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 15

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24

Treatment Resistant Depression Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Treatment Resistant Depression Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

GlobalData Methodology 229


List Of Table

List of Tables

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Region, 2019* 8

Treatment Resistant Depression Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Treatment Resistant Depression Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Treatment Resistant Depression Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Treatment Resistant Depression Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Treatment Resistant Depression Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14

Treatment Resistant Depression Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 15

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Phase, 2019* 22

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24

Treatment Resistant Depression Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Treatment Resistant Depression Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Johnson & Johnson

F. Hoffmann-La Roche Ltd

AstraZeneca Plc

Bristol-Myers Squibb Co

Eli Lilly and Co

Alkermes Plc

The Lundbeck Foundation

Evotec SE

Relmada Therapeutics Inc

BrainCells Inc

Company Profile

Company Profile Title

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Treatment Resistant Depression Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Treatment Resistant Depression Therapeutics Clinical Trials 29

Prominent Drugs 30

Latest Clinical Trials News on Treatment Resistant Depression 31

Oct 15, 2019: Relmada Therapeutics announces top-line results from REL-1017 phase 2 study in individuals with treatment resistant depression 31

Oct 14, 2019: Relmada Therapeutics to announce results of phase 2 study of REL-1017 for treatment resistant depression and conduct Conference Call 31

Clinical Trial Profile Snapshots 32

Appendix 228

Abbreviations 228

Definitions 228

Research Methodology 229

Secondary Research 229

About GlobalData 230

Contact Us 230

Source 231


List Of Figure

List of Figures

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Treatment Resistant Depression Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Treatment Resistant Depression Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Treatment Resistant Depression Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Treatment Resistant Depression Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Treatment Resistant Depression Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14

Treatment Resistant Depression Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 15

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24

Treatment Resistant Depression Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Treatment Resistant Depression Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

GlobalData Methodology 229


List Of Table

List of Tables

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Region, 2019* 8

Treatment Resistant Depression Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Treatment Resistant Depression Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Treatment Resistant Depression Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Treatment Resistant Depression Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Treatment Resistant Depression Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14

Treatment Resistant Depression Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 15

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17

Treatment Resistant Depression Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18

Proportion of Treatment Resistant Depression to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20

Treatment Resistant Depression Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Phase, 2019* 22

Treatment Resistant Depression Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23

Treatment Resistant Depression Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24

Treatment Resistant Depression Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Treatment Resistant Depression Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29

Treatment Resistant Depression Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Johnson & Johnson

F. Hoffmann-La Roche Ltd

AstraZeneca Plc

Bristol-Myers Squibb Co

Eli Lilly and Co

Alkermes Plc

The Lundbeck Foundation

Evotec SE

Relmada Therapeutics Inc

BrainCells Inc